发明名称 |
HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
摘要 |
Disclosed are: a peptide comprising an amino acid sequence composed of contiguous nine amino acid residues derived from a WT1 protein, wherein an amino acid residue at position 2 in the amino acid sequence is selected from the group consisting of Ala, Ile, Leu, Val, Phe, Tyr, Ser and Asp and an amino acid residue at position 9 in the amino acid sequence is Arg; a polynucleotide encoding the peptide; a pharmaceutical composition comprising the peptide; and a method for the induction of a WT1-specific CTL using the peptide. |
申请公布号 |
US8759483(B2) |
申请公布日期 |
2014.06.24 |
申请号 |
US200712280268 |
申请日期 |
2007.02.21 |
申请人 |
International Institute of Cancer Immunology, Inc. |
发明人 |
Sugiyama Haruo |
分类号 |
A61K39/00;C07K7/06 |
主分类号 |
A61K39/00 |
代理机构 |
Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
代理人 |
Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
主权项 |
1. An isolated peptide consisting of 9 contiguous amino acids from a WT1 protein, wherein the 9 contiguous amino acid sequence is Ser Asp Gln Leu Lys Arg His Gln Arg (SEQ ID No: 4).
|
地址 |
Osaka JP |